Axis Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 82 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 3841.16%
- Ebitda -1014.44%
- Net Worth 266.36%
- Total Assets 8.57%
About Axis Biotech
Axis Biotech Private Limited (ABPL) was founded in India on 28 November 1942 and has a glorious history of 82 years and two months.Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Calcutta Nursing Home Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sajan Bajaj and Gourav Bajaj serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110WB1942PTC011115
-
Company No.
011115
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Nov 1942
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Axis Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajan Bajaj
|
Additional Director | 30-Oct-2021 | Current |
|
Gourav Bajaj
|
Additional Director | 14-Sep-2024 | Current |
Financial Performance of Axis Biotech.
Axis Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 3841.16% increase in profit. The company's net worth Soared by an impressive increase of 266.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axis Biotech?
In 2023, Axis Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mrp Commercial Pvt. Ltd.Sajan Bajaj and Gourav Bajaj are mutual person
-
Kishanganj Jute Mills Limited
Sajan Bajaj and Gourav Bajaj are mutual person
-
Axis Mining Private Limited
Sajan Bajaj and Gourav Bajaj are mutual person
-
Axis Nirman And Industries Limited
Sajan Bajaj is a mutual person
-
Gunawate Properties Pvt Ltd
Sajan Bajaj and Gourav Bajaj are mutual person
-
Moongipa Supply Pvt Ltd
Sajan Bajaj and Gourav Bajaj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Axis Biotech?
Unlock and access historical data on people associated with Axis Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
